(Q54283001)

27 May 2018

title

P-Glycoprotein Expression as a Predictor of the Outcome of Therapy for Neuroblastoma (English)

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1056/NEJM199112053252304

28 October 2022

DeBoer G

1 reference

27 May 2018

H. S. Chan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682809

28 October 2022

G. Haddad

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682809

28 October 2022

P. S. Thorner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682809

28 October 2022

G. DeBoer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682809

28 October 2022

Y. P. Lin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682809

28 October 2022

N. Ondrusek

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682809

28 October 2022

H. Yeger

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682809

28 October 2022

V. Ling

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682809

28 October 2022

language of work or name

English

0 references

publication date

1 December 1991

1 reference

27 May 2018

5 December 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1682809

full work available at URL

28 October 2022

http://www.nejm.org/doi/pdf/10.1056/NEJM199112053252304

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1056/NEJM199112053252304

The New England Journal of Medicine

28 October 2022

published in

1 reference

27 May 2018

volume

325

1 reference

27 May 2018

issue

1 reference

27 May 2018

page(s)

1608-1614

1 reference

27 May 2018

Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/316820A0

Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance

1 reference

https://api.crossref.org/works/10.1056/NEJM199112053252304

Identification of members of the P-glycoprotein multigene family

28 October 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199112053252304

Isolation and expression of a complementary DNA that confers multidrug resistance

28 October 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199112053252304

Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine

28 October 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199112053252304

Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues

28 October 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199112053252304

Correlation of MDR1 gene expression with chemotherapy in neuroblastoma.

28 October 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199112053252304

Expression of the multidrug resistance, MDR1, gene in neuroblastomas

28 October 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199112053252304

P-glycoprotein in human sarcoma: evidence for multidrug resistance

28 October 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199112053252304

Detection of P-glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance.

28 October 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199112053252304

Detection of a multidrug resistant phenotype in acute non-lymphoblastic leukaemia.

28 October 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199112053252304

Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.

28 October 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199112053252304

Does P-glycoprotein predict response to chemotherapy?

28 October 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199112053252304

Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood

28 October 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199112053252304

Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro

28 October 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199112053252304

Clinical evaluation of sequentially scheduled cisplatin and VM26 in neuroblastoma: response and toxicity.

28 October 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199112053252304

Sequential cyclophosphamide and doxorubicin for induction of complete remission in children with disseminated neuroblastoma

28 October 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199112053252304

Improved survival at 2 and 5 years in the LMCE1 unselected group of 72 children with stage IV neuroblastoma older than 1 year of age at diagnosis: is cure possible in a small subgroup?

28 October 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199112053252304

Scintigraphic imaging of neuroblastoma with [131-I]iodobenzylguanidine

28 October 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199112053252304

International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma

28 October 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199112053252304

Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas

28 October 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199112053252304

Prognostic factor in neuroblastoma.

28 October 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199112053252304

Biologic differences between neuroblastoma stages IV-S and IV. Measurement of serum ferritin and E-rosette inhibition in 30 children

28 October 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199112053252304

Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas

28 October 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199112053252304

Nonradioactive DNA detection on Southern blots by enzymatically triggered chemiluminescence

28 October 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199112053252304

Raised neuron-specific enolase in serum of children with metastatic neuroblastoma. A report from the Children's Cancer Study Group

28 October 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199112053252304

Tumour karyotype discriminates between good and bad prognostic outcome in neuroblastoma

28 October 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199112053252304

Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma

28 October 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199112053252304

The role of surgery in localized neuroblastoma

28 October 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199112053252304

Multiagent chemotherapy for children with metastatic neuroblastoma: a report from Childrens Cancer Study Group

28 October 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199112053252304

Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies

28 October 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199112053252304

The unlabeled antibody enzyme method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes

28 October 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199112053252304

IV-S neuroblastoma: a cooperative study of 30 children

28 October 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199112053252304

Nonparametric Estimation from Incomplete Observations

28 October 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199112053252304

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design

28 October 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199112053252304

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

28 October 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199112053252304

Multidrug resistance: P-glycoprotein and its allies--the elusive foes.

28 October 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199112053252304

28 October 2022

Identifiers

DOI

1 reference

27 May 2018

1 reference

27 May 2018